Peplin Research Pty Ltd.
5Patents
0Active
5Granted
25Portfolio score
Filing activity: Jun 21, 2001 → Jan 3, 2006
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7449492B2 | Therapeutic agents—I | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6844013B2 | Methods of stimulating the immune system | Human Necessities | 8 | Expired |
| US7378445B2 | Treatment of prostate cancer | Human Necessities | 5 | Expired |
| US7410656B2 | Anti-cancer compounds | Human Necessities | 3 | Expired |
| US7838555B2 | Macrocyclic diterpenes for the treatment and prophylaxis of acne vulgaris | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.